| [1] |
Davis L, Park F. Gene therapy research for kidney diseases [J]. Physiol Genomics, 2019, 51(9): 449-461.
|
| [2] |
Isaka Y. Gene therapy targeting kidney diseases: routes and vehicles [J]. Clin Exp Nephrol, 2006, 10(4): 229-235.
|
| [3] |
Hanss B, Bruggeman LA. Applications of gene therapy to kidney disease [J]. Curr Opin Nephrol Hypertens, 2003, 12(4): 439-445.
|
| [4] |
Fisher KJ, Jooss K, Alston J, et al. Recombinant adeno-associated virus for muscle-directed gene therapy [J]. Nat Med, 1997, 3(3): 306-312.
|
| [5] |
Bell SC, Mall MA, Gutierrez H, et al. The future of cystic fibrosis care: a global perspective [J]. Lancet Respir Med, 2020, 8(1): 65-124.
|
| [6] |
Miller DG, Stamatoyannopoulos G. Gene therapy for hemophilia [J]. N Engl J Med, 2001, 344(23): 1782-1784.
|
| [7] |
Streck CJ, Dickson PV, Ng CY, et al. Antitumor efficacy of AAV-mediated systemic delivery of interferon-β [J]. Cancer Gene Ther, 2006, 13(1): 99-106.
|
| [8] |
Hoyng SA, De Winter F, Gnavi S, et al. Gene delivery to rat and human Schwann cells and nerve segments: a comparison of AAV 1-9 and lentiviral vectors [J]. Gene Ther, 2015, 22(10): 767-780.
|
| [9] |
Takeda S, Takahashi M, Mizukami H, et al. Successful gene transfer using adeno-associated virus vectors into the kidney: comparison among adeno-associated virus serotype 1-5 vectors in vitro and in vivo [J]. Nephron Exp Nephrol, 2004, 96(4): e119-e126.
|
| [10] |
Opie SR, Warrington KH, McKenna MA, et al. Identification of amino acid residues in the capsid proteins of adeno-associated virus type 2 that contribute to heparan sulfate proteoglycan binding [J]. J Virol, 2003, 77(12): 6995-7006.
|
| [11] |
彭建强，谭淑萍，董小岩，等. 2型重组腺相关病毒体外转导培养细胞的研究[J]. 病毒学报，2004, 20(2): 128-132.
|
| [12] |
Shao W, Pei X, Cui C, et al. Superior human hepatocyte transduction with adeno-associated virus vector serotype 7 [J]. Gene Ther, 2019, 26(12): 504-514.
|
| [13] |
Hanlon KS, Kleinstiver BP, Garcia SP, et al. High levels of AAV vector integration into CRISPR-induced DNA breaks [J]. Nat Commun, 2019, 10(1): 4439.
|
| [14] |
Li C, Bowles DE, Dyke T, et al. Adeno-associated virus vectors: potential applications for cancer gene therapy [J]. Cancer Gene Ther, 2005, 12(12): 913-925.
|
| [15] |
Chamberlain JR, Schwarze U, Wang PR, et al. Gene targeting in stem cells from individuals with osteogenesis imperfecta [J]. Science, 2004, 303(5661): 1198-1201.
|
| [16] |
van Breukelen B, Kanellopoulos PN, Tucker PA, et al. The formation of a flexible DNA-binding protein chain is required for efficient DNA unwinding and adenovirus DNA chain elongation [J]. J Biol Chem, 2000, 275(52): 40897-40903.
|
| [17] |
Ginocchio VM, Ferla R, Auricchio A, et al. Current status on clinical development of adeno-associated virus-mediated liver-directed gene therapy for inborn errors of metabolism [J]. Hum Gene Ther, 2019, 30(10): 1204-1210.
|
| [18] |
Moullier P, Friedlander G, Calise D, et al. Adenoviral-mediated gene transfer to renal tubular cells in vivo [J]. Kidney Int, 1994, 45(4): 1220-1225.
|
| [19] |
Lai LW, Chan DM, Erickson RP, et al. Correction of renal tubular acidosis in carbonic anhydrase ii-deficient mice with gene therapy [J]. J Clin Invest, 1998, 10(7): 1320-1325.
|
| [20] |
Lien YH, Lai LW. Liposome-mediated gene transfer into the tubules [J]. Exp Nephrol, 1997, 5(2): 132-136.
|
| [21] |
Heikkila P, Parpala T, Lukkarinen O, et al. Adenovirus-mediated gene transfer into kidney glomeruli using an ex vivo and in vivo kidney perfusion system: first steps towards gene therapy of Alport syndrome [J]. Gene Ther, 1996, 3(1): 21-27.
|
| [22] |
Rocca CJ, Cherqui S. Gene transfer to mouse kidney in vivo [J]. Methods Mol Biol, 2019, 1937: 227-234.
|
| [23] |
Noiri E, Peresleni T, Miller F, et al. In vivo targeting of inducible NO synthase with oligodeoxynucleotides protects rat kidney against ischemia [J]. J Clin Invest, 1996, 97(10): 2377-2783.
|
| [24] |
Haller H, Maasch C, Dragun D, et al. Antisense oligodeoxynucleotide strategies in renal and cardiovascular disease [J]. Kidney Int, 1998, 53(6): 1550-1558.
|
| [25] |
Yang B, Ma T, Dong JY, et al. Partial correction of the urinary concentrating defect in aquaporin-1 null mice by adenovirus-mediated gene delivery [J]. Hum Gene Ther, 2000, 11(4): 567-575.
|
| [26] |
Cheng QL, Chen XM, Li F, et al. Effects of ICAM-1 antisense oligonucleotide on the tubulointerstitium in mice with unilateral ureteral obstruction [J]. Kidney Int, 2000, 57(1): 183-190.
|
| [27] |
Choi YK, Kim YJ, Park HS, et al. Suppression of glomerulosclerosis by adenovirus-mediated IL-10 expression in the kidney [J]. Gene Ther, 2003, 10(7): 559-568.
|
| [28] |
Gusella GL, Fedorova E, Hanss B, et al. Lentiviral gene transduction of kidney [J]. Hum Gene Ther, 2002, 13(3): 407-414.
|
| [29] |
Hwang J, Singh N, Long C, et al. The lentiviral system construction for highly expressed porcine stearoyl-CoA desaturase-1 and functional characterization in stably transduced porcine swine kidney cells [J]. Lipids, 2018, 53(10): 933-945.
|
| [30] |
黄云剑，赵景宏，张憬，等. Smad6和Smad7基因治疗对肾小管间质纤维化进程的影响[J]. 中华肾脏病杂志，2004, 20(5): 358-363.
|
| [31] |
Lipkowitz MS, Hanss B, Tulchin N, et al. Transduction of renal cells in vitro and in vivo by adeno-associated virus gene therapy vectors [J]. J Am Soc Nephrol, 1999, 10(9): 1908-1915.
|
| [32] |
Chen S, Agarwal A, Glushakova OY, et al. Gene delivery in renal tubular epithelial cells using recombinant adeno-associated viral vectors [J]. J Am Soc Nephrol, 2003, 14(4): 947-958.
|
| [33] |
Wang X, Skelley L, Cade R, et al. AAV delivery of mineralocorticoid receptor shRNA prevents progression of cold-induced hypertension and attenuates renal damage [J]. Gene Therapy, 2006, 13(14): 1097-1103.
|
| [34] |
蔡美顺，于仲元，田松，等. 肾囊药物向肾组织内转运的实验研究[J]. 中华医学杂志，2001, 81(6): 360-363.
|
| [35] |
朱虎章，王文洁，黄大伟，等. 肾囊注射甲基泼尼松龙治疗糖尿病肾病的临床研究[J]. 中国中西医结合肾病杂志，2003, 4(7): 412.
|
| [36] |
赵慧萍，李欣，甘良英，等. 大鼠肾囊内β-半乳糖苷酶基因注入及其在肾脏内的局部表达[J]. 中国血液净化，2005, 4(6): 322-325, 335.
|
| [37] |
Goncalves MA, van der Velde I, Janssen JM, et al. Efficient generation and amplification of high-capacity adeno-associated virus/adenovirus hybrid vectors [J]. J Virol, 2002, 76(21): 10734-10744.
|
| [38] |
Wang Y, Camp SM, Niwano M, et al. Herpes simplex virus type 1/adeno-associated virus rep(+) hybrid amplicon vector improves the stability of transgene expression in human cells by site-specific integration [J]. J Viro, 2002, 76(14): 7150-7162.
|
| [39] |
McCarty DM, Monahan PE, Samulski RJ. Self-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesis [J]. Gene Ther, 2001, 8(16): 1248-1254.
|
| [40] |
Chao H, Sun L, Bruce A, et al. Expression of human factor VIII by splicing between dimerized AAV vectors [J]. Mol Ther, 2002, 5(6): 716-722.
|